Top Markets
Coin of the day
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.

Poniard Pharmaceuticals, Inc.

PARD
Clasificación en acciones #42764
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the... Poniard Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the discovery and market introduction of cancer treatments. Its flagship product candidate, Picoplatin, is a platinum-based therapy targeting various cancer types, such as small cell lung, colorectal, prostate, and ovarian cancers. The company has advanced Picoplatin through several clinical stages, including a pivotal Phase III SPEAR trial for small cell lung cancer patients in a second-line treatment setting. Furthermore, Phase II studies investigated Picoplatin as an initial therapy for metastatic colorectal cancer and hormone-refractory prostate cancer. An early-stage Phase I trial also examined an oral formulation of Picoplatin for solid tumors. Founded in 1984 as NeoRx Corporation, the company rebranded to Poniard Pharmaceuticals, Inc. in September 2006 and operates from its base in Seattle, Washington.
Precio por acción
$0.0001
Última sincronización: 2026-08-11
Capitalización bursátil
$150.00
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Poniard Pharmaceuticals, Inc. (PARD)

Categoría

Historial de desdoblamientos de acciones de Poniard Pharmaceuticals, Inc. (PARD)
La acción Poniard Pharmaceuticals, Inc. (símbolo: PARD) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 12, 2026.
Una acción PARD comprada antes de Aug 12, 2026 equivaldría hoy a 0 acciones PARD.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
0 -
CH
0 -
BE
0 -
KR